Inner Mongolia Furui Medical Science Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000KG1
CNY
58.36
1.45 (2.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
494.34
387.63
383.01
330.40
366.89
337.23
319.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
494.34
387.63
383.01
330.40
366.89
337.23
319.82
Raw Material Cost
153.74
122.69
117.64
94.71
140.20
99.31
88.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.97
0.79
0.82
0.65
0.90
0.62
0.66
Selling and Distribution Expenses
170.68
136.92
162.46
148.13
116.12
154.86
139.72
Other Expenses
1.61
1.75
2.28
1.74
2.57
2.20
2.41
Total Expenditure (Excl Depreciation)
341.53
277.93
303.70
260.83
282.97
276.80
253.10
Operating Profit (PBDIT) excl Other Income
152.79999999999998
109.7
79.3
69.6
83.9
60.4
66.7
Other Income
-7.93
1.28
-14.04
-6.59
4.37
5.23
5.10
Operating Profit (PBDIT)
159.80
137.34
86.20
86.68
102.94
89.57
91.65
Interest
0.97
0.79
0.82
0.65
0.90
0.62
0.66
Exceptional Items
-1.52
1.22
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
340.60
264.94
265.37
235.69
226.69
237.92
231.21
Depreciation
26.78
26.78
25.64
25.64
24.05
24.05
23.51
Profit Before Tax
130.54
110.99
59.74
60.40
77.99
64.91
67.49
Tax
30.32
25.37
18.01
18.44
22.94
16.45
17.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.20
59.95
23.30
28.64
11.28
26.64
32.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.20
59.95
23.30
28.64
11.28
26.64
32.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
54.22
24.09
12.98
13.04
25.44
20.77
13.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
96.42
84.04
36.28
41.68
36.73
47.40
46.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,978.32
1,905.44
1,824.94
1,781.97
1,747.68
1,602.84
1,586.86
Earnings per share (EPS)
0.16
0.23
0.09
0.11
0.04
0.1
0.12
Diluted Earnings per share
0.16
0.23
0.09
0.11
0.04
0.1
0.12
Operating Profit Margin (Excl OI)
28.51%
28.19%
19.48%
20.47%
20.31%
17.88%
19.71%
Gross Profit Margin
31.82%
35.54%
22.29%
26.04%
27.81%
26.38%
28.45%
PAT Margin
8.54%
15.47%
6.08%
8.67%
3.08%
7.9%
10.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 34.72% vs 7.53% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 162.67% vs -33.75% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 70.08% vs -8.02% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 11.11% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Inner Mongolia Furui Medical Science Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
494.34
0
494.34
Other Operating Income
0.00
0.00
0.00
Total Operating income
494.34
0
494.34
Raw Material Cost
153.74
0
153.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.97
0
0.97
Selling and Distribution Expenses
170.68
0
170.68
Other Expenses
1.61
0.00
1.61
Total Expenditure (Excl Depreciation)
341.53
0
341.53
Operating Profit (PBDIT) excl Other Income
152.81
0.00
152.81
Other Income
-7.93
0
-7.93
Operating Profit (PBDIT)
159.80
0
159.80
Interest
0.97
0
0.97
Exceptional Items
-1.52
0
-1.52
Gross Profit (PBDT)
340.60
0
340.60
Depreciation
26.78
0
26.78
Profit Before Tax
130.54
0
130.54
Tax
30.32
0
30.32
Provisions and contingencies
0
0
0.00
Profit After Tax
42.20
0
42.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
42.20
0
42.20
Share in Profit of Associates
0
0
0.00
Minority Interest
54.22
0
54.22
Other related items
0.00
0.00
0.00
Consolidated Net Profit
96.42
0
96.42
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,978.32
0
1,978.32
Earnings per share (EPS)
0.16
0
0.16
Diluted Earnings per share
0.16
0
0.16
Operating Profit Margin (Excl OI)
28.51%
0%
0.00
28.51%
Gross Profit Margin
31.82%
0%
0.00
31.82%
PAT Margin
8.54%
0%
0.00
8.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 49.43 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 27.53% vs 1.20% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 34.72% vs 7.53% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.64 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 14.76% vs 131.40% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 162.67% vs -33.75% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.77 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 23.22% vs 35.83% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 70.08% vs -8.02% in Dec 2024

Quarterly - Interest
Interest 0.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 25.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 11.11% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.51%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024